Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) and Ralliant (NYSE:RAL – Get Free Report) are both manufacturing companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.
Earnings & Valuation
This table compares Senseonics Holdings, Inc. Common Stock and Ralliant”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Senseonics Holdings, Inc. Common Stock | $35.26 million | 7.68 | -$69.11 million | ($1.69) | -3.83 |
| Ralliant | $2.07 billion | 2.20 | -$1.22 billion | $1.96 | 20.81 |
Institutional and Insider Ownership
12.4% of Senseonics Holdings, Inc. Common Stock shares are held by institutional investors. 3.6% of Senseonics Holdings, Inc. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of current ratings and price targets for Senseonics Holdings, Inc. Common Stock and Ralliant, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Senseonics Holdings, Inc. Common Stock | 1 | 1 | 3 | 2 | 2.86 |
| Ralliant | 2 | 3 | 7 | 0 | 2.42 |
Senseonics Holdings, Inc. Common Stock currently has a consensus target price of $22.70, suggesting a potential upside of 250.31%. Ralliant has a consensus target price of $50.50, suggesting a potential upside of 23.83%. Given Senseonics Holdings, Inc. Common Stock’s stronger consensus rating and higher probable upside, analysts clearly believe Senseonics Holdings, Inc. Common Stock is more favorable than Ralliant.
Profitability
This table compares Senseonics Holdings, Inc. Common Stock and Ralliant’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Senseonics Holdings, Inc. Common Stock | -195.72% | -102.69% | -54.87% |
| Ralliant | N/A | N/A | N/A |
About Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company’s products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
About Ralliant
Ralliant Corporation is a provider of precision technologies which specializes in designing, developing, manufacturing and servicing precision instruments and engineered products. Ralliant Corporation is based in RALEIGH, N.C.
Receive News & Ratings for Senseonics Holdings Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
